nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—ABCC5—Cisplatin—peripheral nervous system neoplasm	0.225	0.516	CbGbCtD
Dinoprostone—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0788	0.181	CbGbCtD
Dinoprostone—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0603	0.138	CbGbCtD
Dinoprostone—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0482	0.11	CbGbCtD
Dinoprostone—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0236	0.0541	CbGbCtD
Dinoprostone—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000706	0.00192	CcSEcCtD
Dinoprostone—Pain—Melphalan—peripheral nervous system neoplasm	0.000699	0.0019	CcSEcCtD
Dinoprostone—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000698	0.0019	CcSEcCtD
Dinoprostone—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000689	0.00187	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000682	0.00185	CcSEcCtD
Dinoprostone—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00068	0.00185	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000677	0.00184	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000677	0.00184	CcSEcCtD
Dinoprostone—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000676	0.00184	CcSEcCtD
Dinoprostone—Hypertonia—Epirubicin—peripheral nervous system neoplasm	0.000674	0.00183	CcSEcCtD
Dinoprostone—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000672	0.00183	CcSEcCtD
Dinoprostone—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.000672	0.00183	CcSEcCtD
Dinoprostone—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000671	0.00182	CcSEcCtD
Dinoprostone—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000664	0.0018	CcSEcCtD
Dinoprostone—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00066	0.00179	CcSEcCtD
Dinoprostone—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00066	0.00179	CcSEcCtD
Dinoprostone—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00178	CcSEcCtD
Dinoprostone—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00178	CcSEcCtD
Dinoprostone—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00178	CcSEcCtD
Dinoprostone—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000654	0.00178	CcSEcCtD
Dinoprostone—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000654	0.00178	CcSEcCtD
Dinoprostone—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000654	0.00178	CcSEcCtD
Dinoprostone—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000654	0.00178	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.00178	CcSEcCtD
Dinoprostone—Flushing—Etoposide—peripheral nervous system neoplasm	0.00064	0.00174	CcSEcCtD
Dinoprostone—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00064	0.00174	CcSEcCtD
Dinoprostone—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000631	0.00171	CcSEcCtD
Dinoprostone—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00063	0.00171	CcSEcCtD
Dinoprostone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000627	0.0017	CcSEcCtD
Dinoprostone—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000625	0.0017	CcSEcCtD
Dinoprostone—Hypertonia—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.0017	CcSEcCtD
Dinoprostone—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000623	0.00169	CcSEcCtD
Dinoprostone—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000619	0.00168	CcSEcCtD
Dinoprostone—Chills—Etoposide—peripheral nervous system neoplasm	0.000619	0.00168	CcSEcCtD
Dinoprostone—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000617	0.00168	CcSEcCtD
Dinoprostone—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000617	0.00168	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000617	0.00167	CcSEcCtD
Dinoprostone—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000615	0.00167	CcSEcCtD
Dinoprostone—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000614	0.00167	CcSEcCtD
Dinoprostone—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000612	0.00166	CcSEcCtD
Dinoprostone—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00061	0.00166	CcSEcCtD
Dinoprostone—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00061	0.00166	CcSEcCtD
Dinoprostone—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.00165	CcSEcCtD
Dinoprostone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000605	0.00164	CcSEcCtD
Dinoprostone—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000602	0.00164	CcSEcCtD
Dinoprostone—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000599	0.00163	CcSEcCtD
Dinoprostone—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000597	0.00162	CcSEcCtD
Dinoprostone—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000594	0.00161	CcSEcCtD
Dinoprostone—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000594	0.00161	CcSEcCtD
Dinoprostone—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000592	0.00161	CcSEcCtD
Dinoprostone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000586	0.00159	CcSEcCtD
Dinoprostone—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000586	0.00159	CcSEcCtD
Dinoprostone—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000584	0.00159	CcSEcCtD
Dinoprostone—Back pain—Etoposide—peripheral nervous system neoplasm	0.00058	0.00158	CcSEcCtD
Dinoprostone—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000579	0.00157	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000577	0.00157	CcSEcCtD
Dinoprostone—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000577	0.00157	CcSEcCtD
Dinoprostone—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.00156	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000572	0.00155	CcSEcCtD
Dinoprostone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000571	0.00155	CcSEcCtD
Dinoprostone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000566	0.00154	CcSEcCtD
Dinoprostone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000566	0.00154	CcSEcCtD
Dinoprostone—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000565	0.00153	CcSEcCtD
Dinoprostone—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000563	0.00153	CcSEcCtD
Dinoprostone—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.00152	CcSEcCtD
Dinoprostone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000559	0.00152	CcSEcCtD
Dinoprostone—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000558	0.00152	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000553	0.0015	CcSEcCtD
Dinoprostone—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000552	0.0015	CcSEcCtD
Dinoprostone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000552	0.0015	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000551	0.0015	CcSEcCtD
Dinoprostone—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.00149	CcSEcCtD
Dinoprostone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000547	0.00149	CcSEcCtD
Dinoprostone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000547	0.00149	CcSEcCtD
Dinoprostone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000543	0.00147	CcSEcCtD
Dinoprostone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000537	0.00146	CcSEcCtD
Dinoprostone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000535	0.00145	CcSEcCtD
Dinoprostone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000535	0.00145	CcSEcCtD
Dinoprostone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000535	0.00145	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.00145	CcSEcCtD
Dinoprostone—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000531	0.00144	CcSEcCtD
Dinoprostone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000531	0.00144	CcSEcCtD
Dinoprostone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000527	0.00143	CcSEcCtD
Dinoprostone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000526	0.00143	CcSEcCtD
Dinoprostone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000526	0.00143	CcSEcCtD
Dinoprostone—Rash—Topotecan—peripheral nervous system neoplasm	0.000526	0.00143	CcSEcCtD
Dinoprostone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000526	0.00143	CcSEcCtD
Dinoprostone—Cough—Etoposide—peripheral nervous system neoplasm	0.000524	0.00142	CcSEcCtD
Dinoprostone—Headache—Topotecan—peripheral nervous system neoplasm	0.000523	0.00142	CcSEcCtD
Dinoprostone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000522	0.00142	CcSEcCtD
Dinoprostone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000522	0.00142	CcSEcCtD
Dinoprostone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000522	0.00142	CcSEcCtD
Dinoprostone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000522	0.00142	CcSEcCtD
Dinoprostone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000522	0.00142	CcSEcCtD
Dinoprostone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00052	0.00141	CcSEcCtD
Dinoprostone—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000519	0.00141	CcSEcCtD
Dinoprostone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000519	0.00141	CcSEcCtD
Dinoprostone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000519	0.00141	CcSEcCtD
Dinoprostone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000518	0.00141	CcSEcCtD
Dinoprostone—Pain—Vincristine—peripheral nervous system neoplasm	0.000517	0.0014	CcSEcCtD
Dinoprostone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000517	0.0014	CcSEcCtD
Dinoprostone—Rash—Melphalan—peripheral nervous system neoplasm	0.000515	0.0014	CcSEcCtD
Dinoprostone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000515	0.0014	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000513	0.00139	CcSEcCtD
Dinoprostone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000511	0.00139	CcSEcCtD
Dinoprostone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0005	0.00136	CcSEcCtD
Dinoprostone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000499	0.00135	CcSEcCtD
Dinoprostone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000496	0.00135	CcSEcCtD
Dinoprostone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000496	0.00135	CcSEcCtD
Dinoprostone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000496	0.00135	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000494	0.00134	CcSEcCtD
Dinoprostone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000492	0.00134	CcSEcCtD
Dinoprostone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000492	0.00134	CcSEcCtD
Dinoprostone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.00134	CcSEcCtD
Dinoprostone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00049	0.00133	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000487	0.00132	CcSEcCtD
Dinoprostone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000485	0.00132	CcSEcCtD
Dinoprostone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000485	0.00132	CcSEcCtD
Dinoprostone—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000483	0.00131	CcSEcCtD
Dinoprostone—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.00131	CcSEcCtD
Dinoprostone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00048	0.0013	CcSEcCtD
Dinoprostone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000478	0.0013	CcSEcCtD
Dinoprostone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000478	0.0013	CcSEcCtD
Dinoprostone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000478	0.0013	CcSEcCtD
Dinoprostone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000477	0.00129	CcSEcCtD
Dinoprostone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000473	0.00129	CcSEcCtD
Dinoprostone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000463	0.00126	CcSEcCtD
Dinoprostone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00126	CcSEcCtD
Dinoprostone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000458	0.00124	CcSEcCtD
Dinoprostone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000457	0.00124	CcSEcCtD
Dinoprostone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00122	CcSEcCtD
Dinoprostone—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.00121	CcSEcCtD
Dinoprostone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000445	0.00121	CcSEcCtD
Dinoprostone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00044	0.00119	CcSEcCtD
Dinoprostone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000437	0.00119	CcSEcCtD
Dinoprostone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000434	0.00118	CcSEcCtD
Dinoprostone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00043	0.00117	CcSEcCtD
Dinoprostone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00117	CcSEcCtD
Dinoprostone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000427	0.00116	CcSEcCtD
Dinoprostone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000423	0.00115	CcSEcCtD
Dinoprostone—Pain—Etoposide—peripheral nervous system neoplasm	0.000419	0.00114	CcSEcCtD
Dinoprostone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00113	CcSEcCtD
Dinoprostone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000414	0.00112	CcSEcCtD
Dinoprostone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000402	0.00109	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.0004	0.00109	CcSEcCtD
Dinoprostone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.0004	0.00109	CcSEcCtD
Dinoprostone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.00108	CcSEcCtD
Dinoprostone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.00107	CcSEcCtD
Dinoprostone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.00107	CcSEcCtD
Dinoprostone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000394	0.00107	CcSEcCtD
Dinoprostone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000393	0.00107	CcSEcCtD
Dinoprostone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000387	0.00105	CcSEcCtD
Dinoprostone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000387	0.00105	CcSEcCtD
Dinoprostone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000384	0.00104	CcSEcCtD
Dinoprostone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000384	0.00104	CcSEcCtD
Dinoprostone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000384	0.00104	CcSEcCtD
Dinoprostone—Rash—Vincristine—peripheral nervous system neoplasm	0.000381	0.00104	CcSEcCtD
Dinoprostone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000381	0.00103	CcSEcCtD
Dinoprostone—Headache—Vincristine—peripheral nervous system neoplasm	0.000379	0.00103	CcSEcCtD
Dinoprostone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000373	0.00101	CcSEcCtD
Dinoprostone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000366	0.000994	CcSEcCtD
Dinoprostone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000361	0.00098	CcSEcCtD
Dinoprostone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000359	0.000976	CcSEcCtD
Dinoprostone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000974	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000964	CcSEcCtD
Dinoprostone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000351	0.000955	CcSEcCtD
Dinoprostone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000952	CcSEcCtD
Dinoprostone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000948	CcSEcCtD
Dinoprostone—Chills—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000942	CcSEcCtD
Dinoprostone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000938	CcSEcCtD
Dinoprostone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00034	0.000923	CcSEcCtD
Dinoprostone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000337	0.000916	CcSEcCtD
Dinoprostone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000337	0.000915	CcSEcCtD
Dinoprostone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000335	0.00091	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000901	CcSEcCtD
Dinoprostone—Tension—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000897	CcSEcCtD
Dinoprostone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000884	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000881	CcSEcCtD
Dinoprostone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000324	0.00088	CcSEcCtD
Dinoprostone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000879	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000877	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000872	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000868	CcSEcCtD
Dinoprostone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000318	0.000863	CcSEcCtD
Dinoprostone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000861	CcSEcCtD
Dinoprostone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000311	0.000846	CcSEcCtD
Dinoprostone—Rash—Etoposide—peripheral nervous system neoplasm	0.000309	0.000839	CcSEcCtD
Dinoprostone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000309	0.000838	CcSEcCtD
Dinoprostone—Headache—Etoposide—peripheral nervous system neoplasm	0.000307	0.000834	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.00083	CcSEcCtD
Dinoprostone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000302	0.00082	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000818	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000813	CcSEcCtD
Dinoprostone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000803	CcSEcCtD
Dinoprostone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000797	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000797	CcSEcCtD
Dinoprostone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000291	0.00079	CcSEcCtD
Dinoprostone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000789	CcSEcCtD
Dinoprostone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000778	CcSEcCtD
Dinoprostone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000778	CcSEcCtD
Dinoprostone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000778	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000758	CcSEcCtD
Dinoprostone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000746	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000743	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000738	CcSEcCtD
Dinoprostone—Shock—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000734	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.00073	CcSEcCtD
Dinoprostone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000728	CcSEcCtD
Dinoprostone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000721	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00072	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00072	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00072	CcSEcCtD
Dinoprostone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000697	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.00069	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00068	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000679	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000674	CcSEcCtD
Dinoprostone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000247	0.00067	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000667	CcSEcCtD
Dinoprostone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000665	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000645	CcSEcCtD
Dinoprostone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000638	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000629	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.00062	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000615	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00061	CcSEcCtD
Dinoprostone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.00059	CcSEcCtD
Dinoprostone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00059	CcSEcCtD
Dinoprostone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00059	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000564	CcSEcCtD
Dinoprostone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000549	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000546	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000546	CcSEcCtD
Dinoprostone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000535	CcSEcCtD
Dinoprostone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00051	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000508	CcSEcCtD
Dinoprostone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000495	CcSEcCtD
Dinoprostone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000493	CcSEcCtD
Dinoprostone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000474	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000472	CcSEcCtD
Dinoprostone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00047	CcSEcCtD
Dinoprostone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00047	CcSEcCtD
Dinoprostone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000467	CcSEcCtD
Dinoprostone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000456	CcSEcCtD
Dinoprostone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000443	CcSEcCtD
Dinoprostone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000439	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000435	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000435	CcSEcCtD
Dinoprostone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000432	CcSEcCtD
Dinoprostone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00041	CcSEcCtD
Dinoprostone—PTGIR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000127	0.000647	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000127	0.000647	CbGpPWpGaD
Dinoprostone—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	0.000127	0.000647	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000126	0.000646	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000126	0.000646	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000126	0.000645	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000126	0.000645	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000125	0.000637	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ENO2—peripheral nervous system neoplasm	0.000124	0.000633	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000124	0.000633	CbGpPWpGaD
Dinoprostone—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000124	0.000632	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000122	0.000623	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000122	0.000623	CbGpPWpGaD
Dinoprostone—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000121	0.00062	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.00012	0.000611	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000119	0.000611	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000119	0.000609	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000119	0.000608	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000118	0.000603	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000117	0.000598	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000117	0.000596	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000116	0.000595	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000116	0.000595	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000115	0.000588	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000115	0.000586	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000114	0.000584	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000114	0.000582	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000113	0.000578	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000111	0.000568	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000111	0.000566	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000111	0.000566	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000111	0.000566	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	0.00011	0.000562	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	0.00011	0.00056	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000108	0.000552	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000108	0.000551	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000106	0.00054	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	0.000105	0.000539	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000105	0.000538	CbGpPWpGaD
Dinoprostone—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000104	0.000531	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ENO2—peripheral nervous system neoplasm	0.000104	0.00053	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000104	0.00053	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000102	0.000523	CbGpPWpGaD
Dinoprostone—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000102	0.000521	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	0.000101	0.000519	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SLC2A1—peripheral nervous system neoplasm	9.98e-05	0.00051	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.96e-05	0.000509	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	9.93e-05	0.000508	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	9.86e-05	0.000504	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.8e-05	0.000501	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.77e-05	0.000499	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.74e-05	0.000498	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.68e-05	0.000495	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	9.65e-05	0.000493	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	9.52e-05	0.000487	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	9.4e-05	0.000481	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.22e-05	0.000471	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	9.17e-05	0.000469	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ENO2—peripheral nervous system neoplasm	9.09e-05	0.000464	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.05e-05	0.000463	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	9.01e-05	0.000461	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.98e-05	0.000459	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.94e-05	0.000457	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.93e-05	0.000457	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—BCHE—peripheral nervous system neoplasm	8.76e-05	0.000448	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.75e-05	0.000447	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.75e-05	0.000447	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	8.67e-05	0.000443	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.67e-05	0.000443	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	8.61e-05	0.00044	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.5e-05	0.000435	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.37e-05	0.000428	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.36e-05	0.000427	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.34e-05	0.000426	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	8.26e-05	0.000422	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—TH—peripheral nervous system neoplasm	8.24e-05	0.000421	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.2e-05	0.000419	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	8.1e-05	0.000414	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—NRAS—peripheral nervous system neoplasm	8.06e-05	0.000412	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	8.03e-05	0.00041	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	7.99e-05	0.000409	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	7.95e-05	0.000406	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.88e-05	0.000403	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.86e-05	0.000402	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.74e-05	0.000396	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	7.7e-05	0.000393	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.7e-05	0.000393	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.7e-05	0.000393	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.69e-05	0.000393	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—BCHE—peripheral nervous system neoplasm	7.68e-05	0.000392	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.64e-05	0.000391	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	7.58e-05	0.000387	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.48e-05	0.000382	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.48e-05	0.000382	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	7.41e-05	0.000379	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.32e-05	0.000374	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.28e-05	0.000372	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.23e-05	0.000369	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—TH—peripheral nervous system neoplasm	7.22e-05	0.000369	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.13e-05	0.000364	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.13e-05	0.000364	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.09e-05	0.000362	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.85e-05	0.00035	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.84e-05	0.00035	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.73e-05	0.000344	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.73e-05	0.000344	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GNAS—peripheral nervous system neoplasm	6.73e-05	0.000344	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.68e-05	0.000342	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.66e-05	0.00034	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.61e-05	0.000338	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ABCB1—peripheral nervous system neoplasm	6.6e-05	0.000337	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.54e-05	0.000334	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.54e-05	0.000334	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.48e-05	0.000331	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.32e-05	0.000323	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.21e-05	0.000318	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TP53—peripheral nervous system neoplasm	6.17e-05	0.000315	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.1e-05	0.000312	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.02e-05	0.000308	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	6.02e-05	0.000308	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.93e-05	0.000303	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—HRAS—peripheral nervous system neoplasm	5.9e-05	0.000302	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GNAS—peripheral nervous system neoplasm	5.89e-05	0.000301	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.88e-05	0.000301	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.78e-05	0.000296	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	5.69e-05	0.000291	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.63e-05	0.000288	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTPN11—peripheral nervous system neoplasm	5.58e-05	0.000285	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.39e-05	0.000275	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.37e-05	0.000274	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	5.36e-05	0.000274	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.32e-05	0.000272	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	5.29e-05	0.00027	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	5.22e-05	0.000267	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—AKT1—peripheral nervous system neoplasm	5.21e-05	0.000266	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.2e-05	0.000266	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	5.09e-05	0.00026	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.01e-05	0.000256	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	5e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.93e-05	0.000252	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.91e-05	0.000251	CbGpPWpGaD
Dinoprostone—HPGDS—ganglion—peripheral nervous system neoplasm	4.91e-05	0.14	CbGeAlD
Dinoprostone—PTGER2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.87e-05	0.000249	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	4.86e-05	0.000249	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.85e-05	0.000248	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.83e-05	0.000247	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	4.81e-05	0.000246	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	4.81e-05	0.000246	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	4.78e-05	0.000244	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.73e-05	0.000242	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.64e-05	0.000237	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.63e-05	0.000237	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.63e-05	0.000237	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.62e-05	0.000236	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.59e-05	0.000235	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.59e-05	0.000235	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.55e-05	0.000232	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.55e-05	0.000232	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	4.52e-05	0.000231	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.5e-05	0.00023	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.46e-05	0.000228	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.42e-05	0.000226	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ERBB2—peripheral nervous system neoplasm	4.41e-05	0.000226	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.41e-05	0.000225	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.32e-05	0.000221	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.32e-05	0.000221	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.24e-05	0.000217	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.21e-05	0.000215	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	4.15e-05	0.000212	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	4.11e-05	0.00021	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	4.11e-05	0.00021	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.08e-05	0.000209	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.05e-05	0.000207	CbGpPWpGaD
Dinoprostone—SLCO1C1—ganglion—peripheral nervous system neoplasm	4.01e-05	0.114	CbGeAlD
Dinoprostone—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.92e-05	0.0002	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	3.9e-05	0.0002	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	3.86e-05	0.000198	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.83e-05	0.000196	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	3.83e-05	0.000196	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.77e-05	0.000193	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.77e-05	0.000193	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.76e-05	0.000192	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.73e-05	0.000191	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	3.69e-05	0.000189	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	3.68e-05	0.000188	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.67e-05	0.000188	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.62e-05	0.000185	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.6e-05	0.000184	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.6e-05	0.000184	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.59e-05	0.000184	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.59e-05	0.000184	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	3.52e-05	0.00018	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—peripheral nervous system neoplasm	3.51e-05	0.000179	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.48e-05	0.000178	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.47e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.46e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.38e-05	0.000173	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.38e-05	0.000173	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.38e-05	0.000173	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.36e-05	0.000172	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NRAS—peripheral nervous system neoplasm	3.36e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.33e-05	0.00017	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.32e-05	0.00017	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.29e-05	0.000168	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.29e-05	0.000168	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.26e-05	0.000167	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.26e-05	0.000167	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.18e-05	0.000163	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	3.15e-05	0.000161	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—peripheral nervous system neoplasm	3.13e-05	0.00016	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	3.1e-05	0.000159	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.1e-05	0.000158	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.1e-05	0.000158	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.05e-05	0.000156	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.99e-05	0.000153	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.99e-05	0.000153	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.96e-05	0.000151	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.86e-05	0.000146	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.79e-05	0.000143	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.73e-05	0.00014	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.73e-05	0.00014	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.73e-05	0.00014	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.61e-05	0.000134	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.6e-05	0.000133	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.55e-05	0.00013	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.55e-05	0.00013	CbGpPWpGaD
Dinoprostone—SLCO2B1—ganglion—peripheral nervous system neoplasm	2.5e-05	0.0713	CbGeAlD
Dinoprostone—ABCC5—Disease—HRAS—peripheral nervous system neoplasm	2.46e-05	0.000126	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.41e-05	0.000123	CbGpPWpGaD
Dinoprostone—HPGDS—trigeminal ganglion—peripheral nervous system neoplasm	2.41e-05	0.0687	CbGeAlD
Dinoprostone—SLC22A1—ganglion—peripheral nervous system neoplasm	2.39e-05	0.0682	CbGeAlD
Dinoprostone—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.28e-05	0.000116	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—peripheral nervous system neoplasm	2.17e-05	0.000111	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.14e-05	0.000109	CbGpPWpGaD
Dinoprostone—HPGDS—brainstem—peripheral nervous system neoplasm	2.13e-05	0.0608	CbGeAlD
Dinoprostone—PTGIR—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.09e-05	0.000107	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.09e-05	0.000107	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.04e-05	0.000104	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2e-05	0.000102	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2e-05	0.000102	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.92e-05	9.83e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.83e-05	9.38e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—peripheral nervous system neoplasm	1.82e-05	9.28e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.81e-05	9.24e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.8e-05	9.22e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.77e-05	9.03e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.77e-05	9.03e-05	CbGpPWpGaD
Dinoprostone—PTGIR—brainstem—peripheral nervous system neoplasm	1.74e-05	0.0496	CbGeAlD
Dinoprostone—SLCO3A1—trigeminal ganglion—peripheral nervous system neoplasm	1.73e-05	0.0494	CbGeAlD
Dinoprostone—SLCO2A1—trigeminal ganglion—peripheral nervous system neoplasm	1.72e-05	0.0489	CbGeAlD
Dinoprostone—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	1.66e-05	0.0474	CbGeAlD
Dinoprostone—SLCO2A1—parotid gland—peripheral nervous system neoplasm	1.62e-05	0.0462	CbGeAlD
Dinoprostone—CYP11A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-05	8.13e-05	CbGpPWpGaD
Dinoprostone—SLCO4A1—trigeminal ganglion—peripheral nervous system neoplasm	1.58e-05	0.045	CbGeAlD
Dinoprostone—ABCC5—trigeminal ganglion—peripheral nervous system neoplasm	1.57e-05	0.0448	CbGeAlD
Dinoprostone—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.48e-05	7.55e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.45e-05	7.4e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-05	5.96e-05	CbGpPWpGaD
Dinoprostone—SLC22A8—trigeminal ganglion—peripheral nervous system neoplasm	1.08e-05	0.0308	CbGeAlD
Dinoprostone—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.05e-05	5.39e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	9.97e-06	5.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	9.13e-06	4.67e-05	CbGpPWpGaD
Dinoprostone—PTGIR—cerebellum—peripheral nervous system neoplasm	8.57e-06	0.0244	CbGeAlD
Dinoprostone—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	8.51e-06	4.35e-05	CbGpPWpGaD
Dinoprostone—SLCO3A1—cerebellum—peripheral nervous system neoplasm	7.57e-06	0.0216	CbGeAlD
Dinoprostone—SLCO4A1—cerebellum—peripheral nervous system neoplasm	6.89e-06	0.0196	CbGeAlD
Dinoprostone—ABCC5—cerebellum—peripheral nervous system neoplasm	6.85e-06	0.0195	CbGeAlD
Dinoprostone—SLCO2B1—cerebellum—peripheral nervous system neoplasm	5.37e-06	0.0153	CbGeAlD
Dinoprostone—SLCO1A2—cerebellum—peripheral nervous system neoplasm	4.94e-06	0.0141	CbGeAlD
Dinoprostone—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.98e-06	2.04e-05	CbGpPWpGaD
